Literature DB >> 32443032

The Fecal Microbiome in Infants With Biliary Atresia Associates With Bile Flow After Kasai Portoenterostomy.

Mary Elizabeth M Tessier1, Laurel Cavallo1, Jennifer Yeh1, Sanjiv Harpavat1, Kristi L Hoffman2, Joseph F Petrosino2, Benjamin L Shneider1.   

Abstract

BACKGROUND: Biliary atresia's (BA) response to surgical Kasai portoenterostomy (KP) is uneven and dependent upon bile flow; 50% of infants require a liver transplant by 24 months. We hypothesized that the microbiome may identify and associate with outcomes in BA.
METHODS: Stool samples were collected from infants with cholestasis (n = 15), 8 of which with BA were followed longitudinally.16S sequencing was performed on all samples (n = 45). Whole Genome Sequencing (WGS) was performed on BA pre-KP samples (n = 8). Infants with BA, other forms of cholestasis, BA infants with very good bile flow (VGBF) and not (nVGBF) (VGBF dichotomized by TSBA <40 μmol/L by 6 months) were compared.
RESULTS: Of the 8 infants with BA, 4 infants had VGBF. Microbial richness was inversely proportional to degree of cholestasis (P = 0.046). Increased Bifidobacterium abundance associated with VGBF (P = 0.03) and decreased cholestasis (P < 0.01) at 1 month post-KP. Pre-KP, community structure differed in infants with BA versus other cholestasis. Interestingly, infants who subsequently achieved VGBF had increased diversity (P = 0.03) and different community structure at the pre-KP time point. WGS corroborated Bifidobacterium's pre-KP importance.
CONCLUSIONS: The microbiome differs between infants with BA and other cholestasis. It additionally differs between infants with BA who have good and poor bile flow, and thus outcomes, post-KP. These differences are seen even before KP. These data suggest that bile influences the development of the infant microbiome and that there may be possible influences of the pre- and post-KP microbiome on bile flow after KP. Further larger studies are needed to confirm these findings.

Entities:  

Mesh:

Year:  2020        PMID: 32443032     DOI: 10.1097/MPG.0000000000002686

Source DB:  PubMed          Journal:  J Pediatr Gastroenterol Nutr        ISSN: 0277-2116            Impact factor:   2.839


  5 in total

Review 1.  Malnutrition in Biliary Atresia: Assessment, Management, and Outcomes.

Authors:  Julia M Boster; Amy G Feldman; Cara L Mack; Ronald J Sokol; Shikha S Sundaram
Journal:  Liver Transpl       Date:  2021-11-10       Impact factor: 5.799

2.  Discovery of Candidate Stool Biomarker Proteins for Biliary Atresia Using Proteome Analysis by Data-Independent Acquisition Mass Spectrometry.

Authors:  Eiichiro Watanabe; Yusuke Kawashima; Wataru Suda; Tomo Kakihara; Shinya Takazawa; Daisuke Nakajima; Ren Nakamura; Akira Nishi; Kan Suzuki; Osamu Ohara; Jun Fujishiro
Journal:  Proteomes       Date:  2020-11-27

3.  Impact of Two Antibiotic Therapies on Clinical Outcome and Gut Microbiota Profile in Liver Transplant Paediatric Candidates Colonized by Carbapenem-Resistant Klebsiella pneumoniae CR-KP.

Authors:  Sabrina Cardile; Federica Del Chierico; Manila Candusso; Sofia Reddel; Paola Bernaschi; Andrea Pietrobattista; Marco Spada; Giuliano Torre; Lorenza Putignani
Journal:  Front Cell Infect Microbiol       Date:  2021-12-14       Impact factor: 5.293

4.  Adjuvant Therapy with Budesonide Post-Kasai Reduces the Need for Liver Transplantation in Biliary Atresia.

Authors:  Joachim F Kuebler; Omid Madadi-Sanjani; Eva D Pfister; Ulrich Baumann; David Fortmann; Johannes Leonhardt; Benno M Ure; Michael P Manns; Richard Taubert; Claus Petersen
Journal:  J Clin Med       Date:  2021-12-09       Impact factor: 4.241

5.  Gut Microbiota Composition of Biliary Atresia Patients Before Kasai Portoenterostomy Associates With Long-term Outcome.

Authors:  Daan van Wessel; Mark Nomden; Janneke Bruggink; Ruben de Kleine; Alexander Kurilshikov; Henkjan Verkade; Hermie Harmsen; Jan Hulscher
Journal:  J Pediatr Gastroenterol Nutr       Date:  2021-10-01       Impact factor: 3.288

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.